Galectin Therapeutics, Inc. (GALT)

3.89 +0.18 (+4.85%) USD  |  NASDAQ  |  Sep 18, 16:00
3.89 0.00 (0.00%) Pre-Market: 20:00
More

Galectin Therapeutics Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for GALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 14, 2026 --
June 23, 2026 --
May 28, 2026 --
May 15, 2026 --
March 31, 2026 --
August 14, 2025 --
June 17, 2025 --
Date Value
April 02, 2025 --
December 27, 2024 --
November 15, 2024 --
August 16, 2024 --
April 01, 2024 --
April 01, 2024 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Mirum Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade
Savara, Inc. Upgrade